Skip to main content
. 2018 Mar 2;9(21):15437–15450. doi: 10.18632/oncotarget.24602

Figure 1. Mortality and clinical features of aGvHD in the GRdim model.

Figure 1

GRwt and GRdim BALB/c mice were transplanted with BM and purified T cells from C57BL/6 wildtype mice; transfer of BM cells only served as a control. (A) Survival of mice was monitored for 42 days. N = 11 (BM), N = 10 (GRwt), N = 22 (GRdim); data pooled from multiple experiments. (B) Body temperature of mice was analyzed on day 6. N = 6 (BM), N = 7 (GRwt), N = 9 (GRdim); data pooled from multiple experiments. (C, D) Mice were sacrificed on day 6 and serum levels of IL-6 (C) and IFNγ (D) were analyzed by ELISA. N = 7 (BM), N = 9 (GRwt), N = 6 (GRdim) for IL-6; N = 7 (BM), N = 13 (GRwt), N = 15 (GRdim) for IFNγ; data pooled from multiple experiments. All values are depicted as the mean ± SEM. Survival curves were compared using the Gehan-Breslow-Wilcoxon test, statistical analyses of body temperature and cytokine levels were performed by Mann-Whitney U test (*p < 0.05; **p < 0.01; ***p < 0.001; n.s.: non-significant).